Your Clinical Trial Deserves TLC From PRC
When You Need Specialized Expertise for Your Rare & Orphan Research
PRC Clinical Is the Right Clinical Research Organization for Your Next Rare and Orphan Disease Trial
Rare and orphan disease trials are uniquely challenging, from difficulties with diagnosis to trouble with participant identification and enrollment to stress placed on patients and their families.
Having worked with rare disease patients for the past 15 years, PRC Clinical knows how isolating the clinical research experience can be. For early phase orphan and rare disease trials including Phase I and Phase II we know the specialized support required for ensuring high-quality results for your trial.
Rare & Orphan by the Numbers
Rare and orphan drug pipeline is projected to increase 29% in the next five years. (Source)